Your browser doesn't support javascript.
loading
Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib.
Vidarsdottir, Linda; Fernandes, Rita Valador; Zachariadis, Vasilios; Das, Ishani; Edsbäcker, Elin; Sigvaldadottir, Ingibjorg; Azimi, Alireza; Höiom, Veronica; Hansson, Johan; Grandér, Dan; Egyházi Brage, Suzanne; Pokrovskaja Tamm, Katja.
Affiliation
  • Vidarsdottir L; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Fernandes RV; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Zachariadis V; Present address: Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Das I; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Edsbäcker E; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Sigvaldadottir I; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Azimi A; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Höiom V; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Hansson J; Present address: Department of Immunology, Genetics and Pathology, BMC, Uppsala University, Uppsala, Sweden.
  • Grandér D; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Egyházi Brage S; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Pokrovskaja Tamm K; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
Melanoma Res ; 30(5): 443-454, 2020 10.
Article in En | MEDLINE | ID: mdl-32467529
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Antisense / CCAAT-Enhancer-Binding Protein-beta / Vemurafenib / Melanoma Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Melanoma Res Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Antisense / CCAAT-Enhancer-Binding Protein-beta / Vemurafenib / Melanoma Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Melanoma Res Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication: